Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Sacituzumab Govitecan for Intrahepatic Cholangiocarcinoma
Recruiting1 awardPhase 2
Kansas City, Kansas
This trial is testing a treatment called sacituzumab govitecan for patients with a type of cancer called cholangiocarcinoma. This cancer can be locally advanced, recurrent, or
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.